Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Research Article

Clinical Value of 99mTc-octreotide Scintigraphy and Planar X-ray Mammography for the Diagnosis of Breast Cancer

Author(s): Xiaojiang He, Jinxiong Huang, Guibing Chen, Hao Yu, Haojun Chen* and Yesen Li*

Volume 14, Issue 6, 2018

Page: [976 - 980] Pages: 5

DOI: 10.2174/1573405613666170405144425

Price: $65

Abstract

Purpose: The purpose of this study was to compare the value of 99mTc-octreotide scintigraphy and planar X-ray mammography in the diagnosis of breast cancer.

Methods: A total of 65 patients with suspected breast cancer were enrolled. All patients underwent 99mTc-octreotide scintigraphy and planar X-ray mammography. The diagnostic efficiencies of 99mTc-octreotide scintigraphy and planar X-ray mammography were compared based on postsurgery pathology.

Results: The sensitivities of 99mTc-octreotide scintigraphy and planar X-ray mammography in the diagnosis of breast cancer were 90.6% and 66.0%, respectively. The specificities were 00% and 41.7%, while the accuracies were 91.4% and 66.7%, respectively. When 99mTc-octreotide scintigraphy was combined with planar X-ray mammography, the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for breast cancer were 96.2%, 100%, 94.1%, 87.9%, and 36.4%, respectively.

Conclusion: The diagnostic efficiency of 99mTc-octreotide scintigraphy for breast cancer is superior to that of planar X-ray mammography. When combined with planar X-ray mammography, the diagnostic efficiency of 99mTc-octreotide scintigraphy for breast cancer is further increased.

Keywords: 99mTc-octreotide scintigraphy, X-ray mammography, breast cancer, somatostatin, receptor, invasive ductal carcinoma.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy